Alex Denoon

Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience including as GC of a biopharmaceutical company and brings 25 years’ experience advising clients in the sector. In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices. Alex has advised a number of clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products. Alex has been involved in the development of a number of regulatory frameworks and guidelines. Legal 500 describes Alex as "a straight-talking, commercially astute technology specialist who is always willing to take a view" and who delivers "out-of-the-box solutions". · Bristows LLP

EnglandLife Sciences, Regulatory

Email Call Website

About

Partner at Bristows LLP specialising in life sciences regulatory work, with a BSc in Human Genetics and 25 years' experience including in-house service as general counsel of a biopharmaceutical company. He advises on regulatory strategies across the pharmaceuticals and medical devices product lifecycle and acts on contentious matters including judicial review.

Practice areas

Life SciencesRegulatoryPharmaceuticalsMedical DevicesBiotechnologyHealthcareRegulatory Litigation

Office

England

Bristows LLP · Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience including as GC of a biopharmaceutical company and brings 25 years’ experience advising clients in the sector. In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices. Alex has advised a number of clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products. Alex has been involved in the development of a number of regulatory frameworks and guidelines. Legal 500 describes Alex as "a straight-talking, commercially astute technology specialist who is always willing to take a view" and who delivers "out-of-the-box solutions".

England

Expertise

GenomicsCell and Gene Therapies3D PrintingHealthcare AppsCompanion DiagnosticsBorderline ProductsCombination ProductsProduct lifecycle regulatory strategyRegulatory framework and guideline developmentJudicial review (contentious regulatory matters)

Education

University of New South Wales — LLB
University of New South Wales — BSc (Human Genetics)

Admissions

Qualified in Australia, 1995 (Freehills)